COVID-19 Vaccination in Persons with Diabetes: How to Approach Patients

Matthew T. Crow, Erica N. Johnson

Research output: Chapter in Book/Report/Conference proceedingChapter


Since SARS-CoV-2 was first identified as the cause of a cluster of cases of pneumonia in the Hubei Province in China in late 2019, the development and distribution of effective vaccines to prevent severe illness and death from the disease has been a major global priority. Because of the initial concerns about worse disease severity and prognosis in the setting of diabetes mellitus, people with diabetes were an early priority for these vaccines as they became available. The rapid development of vaccines is a remarkable story of collaboration in the scientific community and has become one of the most effective ways to mitigate the impact of the COVID-19 pandemic. This chapter explores what is known about the general approach to vaccination, the duration of vaccines, the impact vaccines have had on hospitalization and mortality in persons with diabetes and COVID-19, and strategies to improve vaccine confidence in patients living with diabetes.

Original languageEnglish (US)
Title of host publicationContemporary Endocrinology
PublisherHumana Press Inc.
Number of pages15
StatePublished - 2023

Publication series

NameContemporary Endocrinology
VolumePart F636
ISSN (Print)2523-3785
ISSN (Electronic)2523-3793


  • COVID-19
  • boosters
  • diabetes mellitus
  • vaccine hesitancy
  • vaccines
  • waning immunity

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'COVID-19 Vaccination in Persons with Diabetes: How to Approach Patients'. Together they form a unique fingerprint.

Cite this